Web Results

dockets.justia.com/docket/north-carolina/ncwdce/1:2017cv00031/86287

Jan 26, 2017 ... Burrell v. Bayer Corporation, et al. Plaintiff: Kristiana Tweed Burrell. Defendant: Bayer Corporation, Bayer Healthcare LLC, Bayer Essure Inc., ...

caselaw.findlaw.com/us-7th-circuit/1489916.html

May 1, 2009 ... BAYER CORPORATION, et al., Defendants-Appellees. Carlos Miguel Pastor, et al., Plaintiffs-Appellants, v. Bridgestone/Firestone North ...

caselaw.findlaw.com/us-7th-circuit/1765609.html

Jan 13, 2017 ... Case opinion for US 7th Circuit JENNIFER DZIK v. BAYER CORPORATION. ... BAYER CORPORATION, et al., Defendants–Appellees.

www.scotusblog.com/case-files/cases/smith-v-bayer-corp

Jun 16, 2011 ... Holding: A federal district court exceeded its authority under the core litigation exception of the Anti-Injunction Act when it enjoined a state court ...

www.labaton.com/en/cases/Sandhaus-v-Bayer-Corp-et-al.cfm

Secured largest consumer recovery in Kansas from a pay-for-delay case. On November 23, 2015, the court granted final approval of a $4.5 million settlement on ...

www.nature.com/onc/journal/v19/n56/full/1204097a.html

Bayer and Agouron have discontinued their ongoing Phase III drug trials of ... Since MMPs also play an important role in tumor angiogenesis (Fang et al., ... et al., 1998; Nelson et al., 2000; Parsons et al., 1997; Wojtowicz-Praga et al., 1997). ..... was developed by Bayer Corporation with selective for MMP-2, MMP-9, MMP- 11, ...

ascopubs.org/doi/full/10.1200/jco.2000.18.1.178

BAY 12-9566 was supplied by Bayer Corporation, Pharmaceutical Division (West Haven, ... The standard linear regression curves of concentration versus peak height ..... Wojtowicz-Praga S, Torri J, Johnson M, et al: Phase I trial of marimastat , ...

academic.oup.com/jnci/article-abstract/93/3/178/2906432/Development-of-Matrix-Metalloproteinase-Inhibitors

Gelatinase A, MMP-2, Gelatin types I, IV, V, and X; laminin V ..... Goel et al. (126), Continuous oral dosing, 100–400 od 400 mg bid, tid, and qid 800 mg bid, All ...

academic.oup.com/annonc/article-pdf/11/12/1579/7011396/11-12-1579.pdf

status of s£ 2 and a life expectancy of at least 12 weeks, and v) absolute granulocytes >1.5 x 109/l, ..... Data on file with Bayer Corporation, West Haven, Connecticut. 18. Wojtowicz-Praga S. Torn J, Johnson M et al. Phase I trial of marimastat ...